Understanding ADHD: Toward an Innovative Therapeutic Intervention
- PMID: 34062853
- PMCID: PMC8147268
- DOI: 10.3390/bioengineering8050056
Understanding ADHD: Toward an Innovative Therapeutic Intervention
Abstract
Attention deficit hyperactivity disorder (ADHD) is a pervasive condition affecting persons across all age groups, although it is primarily diagnosed in children. This neurological condition affects behavior, learning, and social adjustment and requires specific symptomatic criteria to be fulfilled for diagnosis. ADHD may be treated with a combination of psychological or psychiatric therapeutic interventions, but it often goes unattended. People with ADHD face societal bias challenges that impact how they manage the disorder and how they view themselves. This paper summarizes the present state of understanding of this disorder, with particular attention to early diagnosis and innovative therapeutic intervention. Contemporary understanding of the mind-brain duality allows for innovative therapeutic interventions based on neurological stimulation. This paper introduces the concept of neurostimulation as a therapeutic intervention for ADHD and poses the question of the relationship between patient adherence to self-administered therapy and the aesthetic design features of the neurostimulation device. By fabricating devices that go beyond safety and efficacy to embrace the aesthetic preferences of the patient, it is proposed that there will be improvements in patient adherence to a device intended to address ADHD.
Keywords: ADHD; adherence; design; neurostimulation; therapy.
Conflict of interest statement
Guiseppi-Elie is the founder, president, and scientific director of ABTECH Scientific, Inc., a manufacturer of microfabricated electrodes and devices used in biomedical diagnostics and the measurement of physiological data. The funding sponsors had no role in the design of the study; in the collection, analysis, or interpretation of data; in the writing of the manuscript, or in the decision to publish the findings.
Figures




Similar articles
-
Guideline Development for Technological Interventions for Children and Young People to Self-Manage Attention Deficit Hyperactivity Disorder: Realist Evaluation.J Med Internet Res. 2019 Apr 3;21(4):e12831. doi: 10.2196/12831. J Med Internet Res. 2019. PMID: 30942692 Free PMC article.
-
Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years.Cochrane Database Syst Rev. 2019 Jun 21;6(6):CD008223. doi: 10.1002/14651858.CD008223.pub3. Cochrane Database Syst Rev. 2019. PMID: 31222721 Free PMC article.
-
Effects of a Nonwearable Digital Therapeutic Intervention on Preschoolers With Autism Spectrum Disorder in China: Open-Label Randomized Controlled Trial.J Med Internet Res. 2023 Aug 24;25:e45836. doi: 10.2196/45836. J Med Internet Res. 2023. PMID: 37616029 Free PMC article. Clinical Trial.
-
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.CNS Drugs. 2022 Aug;36(8):897-915. doi: 10.1007/s40263-022-00938-w. Epub 2022 Jul 27. CNS Drugs. 2022. PMID: 35896943 Free PMC article. Clinical Trial.
-
[Attention-deficit hyperactivity disorder or bipolar disorder in childhood?].Psychiatriki. 2012 Oct-Dec;23(4):304-13. Psychiatriki. 2012. PMID: 23399752 Review. Greek, Modern.
Cited by
-
Adherence-Promoting Design Features in Pediatric Neurostimulators for ADHD Patients.Bioengineering (Basel). 2024 May 17;11(5):502. doi: 10.3390/bioengineering11050502. Bioengineering (Basel). 2024. PMID: 38790368 Free PMC article.
-
New frontiers in pharmacological treatment of attention-deficit hyperactivity disorder.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 6. doi: 10.1007/s00210-025-04328-z. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40478337 Review.
-
Bioelectronic Therapeutics: A Revolutionary Medical Practice in Health Care.Bioelectricity. 2025 Mar 18;7(1):2-28. doi: 10.1089/bioe.2024.0039. eCollection 2025 Mar. Bioelectricity. 2025. PMID: 40342937 Review.
-
Neurotherapeutics for ADHD: Do they work?Psych J. 2022 Jun;11(3):419-427. doi: 10.1002/pchj.544. Epub 2022 Mar 31. Psych J. 2022. PMID: 35359026 Free PMC article.
References
-
- Force D.-T. Diagnostic and Statistical Manual of Mental Disorders DSM-5. American Psychiatric Association; Philadelphia, PA, USA: 2013. Neurodevelopmental Disorders.
-
- Silver M.D.L., Michele Novotni P.D. What Causes ADHD? Is ADHD Genetic? Yes and No. [(accessed on 29 April 2021)];2019 Available online: https://www.additudemag.com/is-adhd-hereditary-yes-and-no/
-
- Kessler R.C., Adler L., Barkley R., Biederman J., Conners C.K., Demler O., Faraone S.V., Greenhill L.L., Howes M.J., Secnik K., et al. The prevalence and correlates of adult ADHD in the United States: Results from the national comorbidity survey replication. Am. J. Psychiatry. 2006;163:716–723. doi: 10.1176/ajp.2006.163.4.716. - DOI - PMC - PubMed
-
- Danielson M.L., Bitsko R.H., Ghandour R.M., Holbrook J.R., Kogan M.D., Blumberg S.J. Prevalence of parent-reported ADHD diagnosis and associated treatment among, U.S. children and adolescents, 2016. J. Clin. Child Adolesc. Psychol. 2018;47:199–212. doi: 10.1080/15374416.2017.1417860. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources